1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > World Generic Markets 07 DECEMBER 2015

World Generic Markets 07 DECEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - Eisai Expansion Highlights China's Emerging Generic Market Dominance
Industry Brief - Teligent Completes Alveda Acquisition
Industry Brief - Teva Launches Pantoprazole In Canada
Industry Brief - NOC Issued For Generic Oestradiol
Industry Brief - Sandoz Canada Launches New Lorazepam Dosage
Industry Brief - Merck To Enter Canadian Biosimilar Market
Industry Brief - Appellate Court Deals Cubicin Blow To Merck
Industry Brief - Mylan Launches Nevirapine In US
Industry Brief - Mylan Launches Glipizide In US
Industry Brief - Court Delivers Palonosetron Blow To Teva
Industry Brief - Mylan Launches Almotripan In US
Industry Brief - Sandoz' Third Biosimilar Application Accepted By The FDA
Industry Trend Analysis - Amgen A Leader In Race For Biosimilar RA Market
Industry Trend Analysis - Samsung Bioepis Set To Win EU Biosimilar Etanercept First-To-Market Race
Industry Brief - Mylan Initiates Mesalamine Patent Challenge
Industry Brief - Mylan Launches Generic Adderall
Industry Brief - Breckenridge Gains Rabeprazole Approval
Industry Trend Analysis - Hikma And Xellia Will Both Profit From Acquisition Agreement
Industry Brief - Companies Gain Dutasteride Capsule Approvals
Industry Trend Analysis - US Filing Underlines Amgen's Biosimilar Market Leader Ambitions
Industry Brief - Mylan Launches Clozapine
Industry Brief - Lannett Completes KU Acquisition
Industry Brief - Beximco Gains FDA Carvedilol Approval
Industry Brief - Fresenius Kabi Launches Dexmedetomidine
Industry Trend Analysis - Product Switching Strategy Fails But Cannot Be Ruled Out
Industry Brief - Jubilant Gains Paroxetine ANDA Approval
Industry Brief - Ajanta Launches Montelukast In US
Industry Trend Analysis - Stada's Other Key Markets Will Compensate For Continued Russia Woes
Industry Trend Analysis - Next Steps Will Be Crucial Following Mylan/Perrigo Merger Rejection
Industry Brief - Mylan Authorises USD1bn Share Repurchase Plan
Industry Trend Analysis - Spanish Generic Industry Poised To Benefit From Proposed EC SPC Waiver
Industry Brief - Consilient Health Launches Rasagiline
Industry Brief - Dr Reddy's Completes Fondaparinux Acquisition From Alchemia
Industry Trend Analysis - Teva's Presence In Japanese Generic Market Will Increase Through Takeda Partnership
Industry Brief - Samsung Bioepis' Renflexis Biosimilar Approved In South Korea
Industry Trend Analysis - HIV Agreements Pressure Other Companies To Follow Suit
Industry Brief - Teva Proposes Financing Initiatives Ahead Of Actavis Acquisition

Table Of Contents

World Generic Markets 07 DECEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

The Future of Generic Drugs and Strategies for Commercial Success

The Future of Generic Drugs and Strategies for Commercial Success

  • $ 2995
  • Industry report
  • September 2016
  • by CBR Pharma Insights

The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.